Adverse effects of antituberculoses drugs causing changes in treatment
References (10)
- et al.
Serum uric concentrations and arthralgia among patients treated with pyrazinamide-containing regimens in Hong Kong and Singapore
Tubercle
(1981) - et al.
Five years of clinical experience with rifampicin
Acta tubetculosea et pneumologica Belgica
(1971) Adverse reactions to short-course regimens containing streptomycin, isoniazid, pyrazinamide and rifampicin in Hong Kong
Tubercle
(1976)- et al.
La toxicité du pyrazinamide dans les traitements antituberculeux
Revue Francaise des maladies respiratoires
(1980) - et al.
Foi et rifampicine
Poumon et Coeur.
(1973)
There are more references available in the full text version of this article.
Cited by (19)
Prevention and management of tuberculosis in solid organ transplantation: A consensus statement of the transplantation society of Taiwan
2023, Journal of the Formosan Medical AssociationHIV/AIDS treatment: lessons from the tuberculosis experience
1998, Drug Resistance UpdatesDrugs used in tuberculosis and leprosy
1984, Side Effects of Drugs AnnualAnalysis of Adverse Drug Reactions associated with Anti-tubercular drugs – A Retrospective Study
2022, Research Journal of Pharmacy and TechnologyEfficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatment
2015, European Respiratory Journal
Copyright © 1982 Published by Elsevier Ltd.